Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.
PaperCitations, authors & open-access status
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,403 citations, 1996 year and closed oa status.
1,403
Citations
1996
Year
closed
OA Status